These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2339642)

  • 1. Topographical distribution of fluoride in iliac bone of a fluoride-treated osteoporotic patient.
    Bang S; Baud CA
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S87-9. PubMed ID: 2339642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal bone mineralization after fluoride treatment in osteoporosis: a small-angle x-ray-scattering study.
    Fratzl P; Roschger P; Eschberger J; Abendroth B; Klaushofer K
    J Bone Miner Res; 1994 Oct; 9(10):1541-9. PubMed ID: 7817799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-ray microanalysis of fluoride distribution in microfracture calluses in cancellous iliac bone from osteoporotic patients treated with fluoride and untreated.
    Boivin G; Grousson B; Meunier PJ
    J Bone Miner Res; 1991 Nov; 6(11):1183-90. PubMed ID: 1805542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of intrinsic bone quality in vivo by reflection ultrasound: correction of impaired quality with slow-release sodium fluoride and calcium citrate.
    Antich PP; Pak CY; Gonzales J; Anderson J; Sakhaee K; Rubin C
    J Bone Miner Res; 1993 Mar; 8(3):301-11. PubMed ID: 8456586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of patients with postmenopausal and steroid-induced osteoporosis using sodium fluoride combined with vitamin D2 and calcium gluconate].
    Todorova S; Diankova L; Andreeva M; Khristova D; Tsachev K; Kamenova P
    Vutr Boles; 1990; 29(1):77-81. PubMed ID: 2396420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging Versus Postmenopausal Osteoporosis: Bone Composition and Maturation Kinetics at Actively-Forming Trabecular Surfaces of Female Subjects Aged 1 to 84 Years.
    Paschalis EP; Fratzl P; Gamsjaeger S; Hassler N; Brozek W; Eriksen EF; Rauch F; Glorieux FH; Shane E; Dempster D; Cohen A; Recker R; Klaushofer K
    J Bone Miner Res; 2016 Feb; 31(2):347-57. PubMed ID: 26308158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microradiographic study of iliac bone biopsies taken after treatment of postmenopausal osteoporosis with sodium fluoride. Histomorphometric correlations].
    Duriez R; Flautre B; Duriez J
    Rev Rhum Mal Osteoartic; 1989 Apr; 56(5):375-81. PubMed ID: 2727602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Loss of trabecular bone strength and bone quality after 5 years of fluoride therapy for osteoporosis].
    Søgaard CH; Mosekilde L; Richards A; Mosekilde L
    Ugeskr Laeger; 1995 Apr; 157(14):2004-8. PubMed ID: 7740640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and geometric changes in iliac bone: relationship to normal aging and osteoporosis.
    Foldes J; Parfitt AM; Shih MS; Rao DS; Kleerekoper M
    J Bone Miner Res; 1991 Jul; 6(7):759-66. PubMed ID: 1950680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
    Recker RR; Bare SP; Smith SY; Varela A; Miller MA; Morris SA; Fox J
    Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The response of vertebral bone mineral density during the treatment of osteoporosis with sodium fluoride.
    Hodsman AB; Drost DJ
    J Clin Endocrinol Metab; 1989 Nov; 69(5):932-8. PubMed ID: 2793995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bone complications of fluorotherapy: influence of androgen deficiency].
    Weryha G; Aghassian C; Morel J; Leclère J; Hartemann P
    Ann Endocrinol (Paris); 1990; 51(5-6):218-21. PubMed ID: 2130762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.
    Riggs BL; Hodgson SF; O'Fallon WM; Chao EY; Wahner HW; Muhs JM; Cedel SL; Melton LJ
    N Engl J Med; 1990 Mar; 322(12):802-9. PubMed ID: 2407957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative effects of sodium fluoride and hormonal replacement therapy on bone metabolism in osteoporotic women with high fracture risk. Results of monitoring for 2 years].
    Pouillès JM; Trémollières F; Ribot C
    Rev Rhum Mal Osteoartic; 1992 Feb; 59(2):103-13. PubMed ID: 1604221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium.
    Lindsay R; Zhou H; Cosman F; Nieves J; Dempster DW; Hodsman AB
    J Bone Miner Res; 2007 Apr; 22(4):495-502. PubMed ID: 17227219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In postmenopausal osteoporosis the bone increasing effect of monofluorophosphate is not dependent on serum fluoride.
    Rigalli A; Pera L; Morosano M; Masoni A; Bocanera R; Tozzini R; Puche RC
    Medicina (B Aires); 1999; 59(2):157-61. PubMed ID: 10413893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis.
    Pak CY; Adams-Huet B; Sakhaee K; Bell NH; Licata A; Johnston C; Rubin B; Bonnick S; Piziak V; Graham H; Ballard J; Berger R; Fears W; Breslau N; Rubin C
    J Bone Miner Res; 1996 Feb; 11(2):160-8. PubMed ID: 8822339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of strontium and mineralization in iliac bone biopsies from osteoporotic women treated long-term with strontium ranelate.
    Doublier A; Farlay D; Khebbab MT; Jaurand X; Meunier PJ; Boivin G
    Eur J Endocrinol; 2011 Sep; 165(3):469-76. PubMed ID: 21690207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures.
    Gutteridge DH; Stewart GO; Prince RL; Price RI; Retallack RW; Dhaliwal SS; Stuckey BG; Drury P; Jones CE; Faulkner DL; Kent GN; Bhagat CI; Nicholson GC; Jamrozik K
    Osteoporos Int; 2002; 13(2):158-70. PubMed ID: 11908491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of bone fluoride determination in osteoporotic patients treated with sodium fluoride].
    Laurent V; de Vernejoul MC; Brouard A; Terrier JL; Miravet L; Kuntz D
    Presse Med; 1989 Apr; 18(13):679-82. PubMed ID: 2524040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.